GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the GoodRx Second Quarter 2023 Earnings Conference Call and Webcast. [Operator instructions].

Related Keywords

United States ,Americans ,Eric Sheridan ,George Hill ,Sandy Draper ,Stan Berenshteyn ,Daniel Grosslight ,Charles Rhyee ,Karsten Voermann ,Robert Simmons ,Craig Hettenbach ,Whitney Notaro ,Thomas Kelliher ,Andrew Warren ,Mark Mahaney ,Andrew Slutsky ,Mccoy Madson ,Jailendra Singh ,Scott Wagner ,Jonathan Yong ,Dorothy Gemmell ,Jian Li ,Raj Beri ,Express ,Nasdaq ,Da Davidson Co ,Kroger Savings Club ,Kroger ,Wells Fargo Securities ,Morgan Stanley ,Pharma Manufacturer Solutions ,Exchange Commission ,Credit Suisse ,Vitacare Services ,Deutsche Bank ,Goodrx Holdings Inc ,Manufacturer Solutions ,We See Pharma Manufacturer Solutions ,Goodrx Health ,Goldman Sachs ,Goodrx Holdings ,Call Transcript August ,Goodrx Second Quarter ,Conference Call ,Vice President ,Interim Chief Executive Officer ,Chief Financial ,Chief Operating Officer ,Risk Factors ,Annual Report ,Investor Relations ,Express Scripts ,Express Script Price Assure ,Caremark Cost Saver ,Chief Commercial Officer ,Chief Marketing ,Cost Saver ,Pharma Man Sol ,Coy Madson ,Sean Dodge ,Man Sol ,